Stoddard David G, Keeney Michael G, Gao Ge, Smith David I, García Joaquín J, O'Brien Erin K
Department of Otorhinolaryngology, Mayo Clinic, Rochester, Minnesota, USA
Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Otolaryngol Head Neck Surg. 2015 Apr;152(4):752-8. doi: 10.1177/0194599815571285. Epub 2015 Feb 27.
Assess human papilloma virus (HPV) transcriptional activity in inverted Schneiderian papillomas (IPs).
Case series with chart review.
Academic tertiary care center.
Retrospective clinicopathologic review of 19 cases of IP in patients undergoing surgical excision from 1995 to 2013 at Mayo Clinic in Rochester, Minnesota. Surgical pathology archival material was histopathologically reviewed using hematoxylin and eosin-stained slides. Formalin-fixed, paraffin-embedded material from each case was evaluated for p16 expression using immunohistochemistry as well as HPV DNA and E6/E7 messenger RNA (mRNA) transcription using polymerase chain reaction (PCR) and in situ hybridization (via RNAscope technology), respectively.
Eight patients were female (42%), with an average age of 53 years (range, 23-82 years). Three demonstrated malignancy, and 5 subsequently recurred. Average follow-up was 49 months (range, 0-200 months), and 1 patient died from squamous cell carcinoma arising from the IP. RNAscope detected HPV mRNA transcripts exclusively within IP in 100% of cases; however, in 11 patients (58%), less than 1% of cells exhibited transcriptional activity. Only 2 of 19 cases (11%) demonstrated mRNA activity in 50% or more cells. HPV DNA was detected in only 2 specimens by PCR.
This study reveals wide prevalence but limited transcriptional activity of HPV in IP. No correlation between HPV transcriptional activity and progression, recurrence, or malignant transformation was identified. These data suggest that transcription of HPV may contribute to the pathogenesis of IP, but prospective data are needed to definitively demonstrate this connection. These results also suggest that RNAscope may be more sensitive than PCR in detecting HPV activity in IP.
评估人乳头瘤病毒(HPV)在倒生性 Schneiderian 乳头状瘤(IP)中的转录活性。
病例系列并进行图表回顾。
学术性三级医疗中心。
对1995年至2013年在明尼苏达州罗切斯特市梅奥诊所接受手术切除的19例IP患者进行回顾性临床病理分析。手术病理存档材料采用苏木精和伊红染色切片进行组织病理学检查。对每个病例的福尔马林固定、石蜡包埋材料分别采用免疫组织化学评估p16表达,采用聚合酶链反应(PCR)和原位杂交(通过RNAscope技术)评估HPV DNA和E6/E7信使核糖核酸(mRNA)转录。
8例患者为女性(42%),平均年龄53岁(范围23 - 82岁)。3例显示为恶性,5例随后复发。平均随访时间为49个月(范围0 - 200个月),1例患者死于IP引发的鳞状细胞癌。RNAscope在100%的病例中仅在IP内检测到HPV mRNA转录本;然而,11例患者(58%)中,不到1%的细胞表现出转录活性。19例病例中仅2例(11%)在50%或更多细胞中显示出mRNA活性。通过PCR仅在2份标本中检测到HPV DNA。
本研究揭示了HPV在IP中广泛存在但转录活性有限。未发现HPV转录活性与进展、复发或恶性转化之间存在相关性。这些数据表明HPV转录可能参与了IP的发病机制,但需要前瞻性数据来明确证实这种联系。这些结果还表明,在检测IP中的HPV活性方面,RNAscope可能比PCR更敏感。